The global Consumer Healthcare Drug market was valued at 126860 million in 2024 and is projected to reach US$ 188390 million by 2031, at a CAGR of 6.0% during the forecast period.
Consumer health products are products sold directly to consumers. Unlike prescription drugs, selection and use of consumer health products does not require the oversight of a health care practitioner.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Consumer Healthcare Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Consumer Healthcare Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Consumer Healthcare Drug. This report contains market size and forecasts of Consumer Healthcare Drug in global, including the following market information:
Global Consumer Healthcare Drug market revenue, 2020-2025, 2026-2031, ($ millions)
Global top five Consumer Healthcare Drug companies in 2024 (%)
Total Market by Segment:
Global Consumer Healthcare Drug market, by Type, 2020-2025, 2026-2031 ($ millions)
Global Consumer Healthcare Drug market segment percentages, by Type, 2024 (%)
Solid Preparations
Oral Liquid
Patch
Other
Global Consumer Healthcare Drug market, by Application, 2020-2025, 2026-2031 ($ millions)
Global Consumer Healthcare Drug market segment percentages, by Application, 2024 (%)
Hospital
Retail Pharmacy
Other
Global Consumer Healthcare Drug market, by region and country, 2020-2025, 2026-2031 ($ millions)
Global Consumer Healthcare Drug market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Consumer Healthcare Drug revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Consumer Healthcare Drug revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
AbbVie
Merck & Co.
GlaxoSmithKline
Pfizer
Sanofi
Takeda
Bayer
Teva
Sinopharm Group
CR Pharmaceutical
Shanghai Pharmaceuticals
Hualan Bio
North China Pharmaceutical
Hengrui Medicine
Fosun Pharma
East China Medicine
Livzon Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Consumer Healthcare Drug, market overview.
Chapter 2: Global Consumer Healthcare Drug market size in revenue.
Chapter 3: Detailed analysis of Consumer Healthcare Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Consumer Healthcare Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Consumer Healthcare Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Consumer Healthcare Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Consumer Healthcare Drug Overall Market Size
2.1 Global Consumer Healthcare Drug Market Size: 2024 VS 2031
2.2 Global Consumer Healthcare Drug Market Size, Prospects & Forecasts: 2020-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Consumer Healthcare Drug Players in Global Market
3.2 Top Global Consumer Healthcare Drug Companies Ranked by Revenue
3.3 Global Consumer Healthcare Drug Revenue by Companies
3.4 Top 3 and Top 5 Consumer Healthcare Drug Companies in Global Market, by Revenue in 2024
3.5 Global Companies Consumer Healthcare Drug Product Type
3.6 Tier 1, Tier 2, and Tier 3 Consumer Healthcare Drug Players in Global Market
3.6.1 List of Global Tier 1 Consumer Healthcare Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Consumer Healthcare Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Consumer Healthcare Drug Market Size Markets, 2024 & 2031
4.1.2 Solid Preparations
4.1.3 Oral Liquid
4.1.4 Patch
4.1.5 Other
4.2 Segmentation by Type - Global Consumer Healthcare Drug Revenue & Forecasts
4.2.1 Segmentation by Type - Global Consumer Healthcare Drug Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Consumer Healthcare Drug Revenue, 2026-2031
4.2.3 Segmentation by Type - Global Consumer Healthcare Drug Revenue Market Share, 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Consumer Healthcare Drug Market Size, 2024 & 2031
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 Segmentation by Application - Global Consumer Healthcare Drug Revenue & Forecasts
5.2.1 Segmentation by Application - Global Consumer Healthcare Drug Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Consumer Healthcare Drug Revenue, 2026-2031
5.2.3 Segmentation by Application - Global Consumer Healthcare Drug Revenue Market Share, 2020-2031
6 Sights by Region
6.1 By Region - Global Consumer Healthcare Drug Market Size, 2024 & 2031
6.2 By Region - Global Consumer Healthcare Drug Revenue & Forecasts
6.2.1 By Region - Global Consumer Healthcare Drug Revenue, 2020-2025
6.2.2 By Region - Global Consumer Healthcare Drug Revenue, 2026-2031
6.2.3 By Region - Global Consumer Healthcare Drug Revenue Market Share, 2020-2031
6.3 North America
6.3.1 By Country - North America Consumer Healthcare Drug Revenue, 2020-2031
6.3.2 United States Consumer Healthcare Drug Market Size, 2020-2031
6.3.3 Canada Consumer Healthcare Drug Market Size, 2020-2031
6.3.4 Mexico Consumer Healthcare Drug Market Size, 2020-2031
6.4 Europe
6.4.1 By Country - Europe Consumer Healthcare Drug Revenue, 2020-2031
6.4.2 Germany Consumer Healthcare Drug Market Size, 2020-2031
6.4.3 France Consumer Healthcare Drug Market Size, 2020-2031
6.4.4 U.K. Consumer Healthcare Drug Market Size, 2020-2031
6.4.5 Italy Consumer Healthcare Drug Market Size, 2020-2031
6.4.6 Russia Consumer Healthcare Drug Market Size, 2020-2031
6.4.7 Nordic Countries Consumer Healthcare Drug Market Size, 2020-2031
6.4.8 Benelux Consumer Healthcare Drug Market Size, 2020-2031
6.5 Asia
6.5.1 By Region - Asia Consumer Healthcare Drug Revenue, 2020-2031
6.5.2 China Consumer Healthcare Drug Market Size, 2020-2031
6.5.3 Japan Consumer Healthcare Drug Market Size, 2020-2031
6.5.4 South Korea Consumer Healthcare Drug Market Size, 2020-2031
6.5.5 Southeast Asia Consumer Healthcare Drug Market Size, 2020-2031
6.5.6 India Consumer Healthcare Drug Market Size, 2020-2031
6.6 South America
6.6.1 By Country - South America Consumer Healthcare Drug Revenue, 2020-2031
6.6.2 Brazil Consumer Healthcare Drug Market Size, 2020-2031
6.6.3 Argentina Consumer Healthcare Drug Market Size, 2020-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Consumer Healthcare Drug Revenue, 2020-2031
6.7.2 Turkey Consumer Healthcare Drug Market Size, 2020-2031
6.7.3 Israel Consumer Healthcare Drug Market Size, 2020-2031
6.7.4 Saudi Arabia Consumer Healthcare Drug Market Size, 2020-2031
6.7.5 UAE Consumer Healthcare Drug Market Size, 2020-2031
7 Companies Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Consumer Healthcare Drug Major Product Offerings
7.1.4 Johnson & Johnson Consumer Healthcare Drug Revenue in Global Market (2020-2025)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 AbbVie
7.2.1 AbbVie Corporate Summary
7.2.2 AbbVie Business Overview
7.2.3 AbbVie Consumer Healthcare Drug Major Product Offerings
7.2.4 AbbVie Consumer Healthcare Drug Revenue in Global Market (2020-2025)
7.2.5 AbbVie Key News & Latest Developments
7.3 Merck & Co.
7.3.1 Merck & Co. Corporate Summary
7.3.2 Merck & Co. Business Overview
7.3.3 Merck & Co. Consumer Healthcare Drug Major Product Offerings
7.3.4 Merck & Co. Consumer Healthcare Drug Revenue in Global Market (2020-2025)
7.3.5 Merck & Co. Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Corporate Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Consumer Healthcare Drug Major Product Offerings
7.4.4 GlaxoSmithKline Consumer Healthcare Drug Revenue in Global Market (2020-2025)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Consumer Healthcare Drug Major Product Offerings
7.5.4 Pfizer Consumer Healthcare Drug Revenue in Global Market (2020-2025)
7.5.5 Pfizer Key News & Latest Developments
7.6 Sanofi
7.6.1 Sanofi Corporate Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Consumer Healthcare Drug Major Product Offerings
7.6.4 Sanofi Consumer Healthcare Drug Revenue in Global Market (2020-2025)
7.6.5 Sanofi Key News & Latest Developments
7.7 Takeda
7.7.1 Takeda Corporate Summary
7.7.2 Takeda Business Overview
7.7.3 Takeda Consumer Healthcare Drug Major Product Offerings
7.7.4 Takeda Consumer Healthcare Drug Revenue in Global Market (2020-2025)
7.7.5 Takeda Key News & Latest Developments
7.8 Bayer
7.8.1 Bayer Corporate Summary
7.8.2 Bayer Business Overview
7.8.3 Bayer Consumer Healthcare Drug Major Product Offerings
7.8.4 Bayer Consumer Healthcare Drug Revenue in Global Market (2020-2025)
7.8.5 Bayer Key News & Latest Developments
7.9 Teva
7.9.1 Teva Corporate Summary
7.9.2 Teva Business Overview
7.9.3 Teva Consumer Healthcare Drug Major Product Offerings
7.9.4 Teva Consumer Healthcare Drug Revenue in Global Market (2020-2025)
7.9.5 Teva Key News & Latest Developments
7.10 Sinopharm Group
7.10.1 Sinopharm Group Corporate Summary
7.10.2 Sinopharm Group Business Overview
7.10.3 Sinopharm Group Consumer Healthcare Drug Major Product Offerings
7.10.4 Sinopharm Group Consumer Healthcare Drug Revenue in Global Market (2020-2025)
7.10.5 Sinopharm Group Key News & Latest Developments
7.11 CR Pharmaceutical
7.11.1 CR Pharmaceutical Corporate Summary
7.11.2 CR Pharmaceutical Business Overview
7.11.3 CR Pharmaceutical Consumer Healthcare Drug Major Product Offerings
7.11.4 CR Pharmaceutical Consumer Healthcare Drug Revenue in Global Market (2020-2025)
7.11.5 CR Pharmaceutical Key News & Latest Developments
7.12 Shanghai Pharmaceuticals
7.12.1 Shanghai Pharmaceuticals Corporate Summary
7.12.2 Shanghai Pharmaceuticals Business Overview
7.12.3 Shanghai Pharmaceuticals Consumer Healthcare Drug Major Product Offerings
7.12.4 Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue in Global Market (2020-2025)
7.12.5 Shanghai Pharmaceuticals Key News & Latest Developments
7.13 Hualan Bio
7.13.1 Hualan Bio Corporate Summary
7.13.2 Hualan Bio Business Overview
7.13.3 Hualan Bio Consumer Healthcare Drug Major Product Offerings
7.13.4 Hualan Bio Consumer Healthcare Drug Revenue in Global Market (2020-2025)
7.13.5 Hualan Bio Key News & Latest Developments
7.14 North China Pharmaceutical
7.14.1 North China Pharmaceutical Corporate Summary
7.14.2 North China Pharmaceutical Business Overview
7.14.3 North China Pharmaceutical Consumer Healthcare Drug Major Product Offerings
7.14.4 North China Pharmaceutical Consumer Healthcare Drug Revenue in Global Market (2020-2025)
7.14.5 North China Pharmaceutical Key News & Latest Developments
7.15 Hengrui Medicine
7.15.1 Hengrui Medicine Corporate Summary
7.15.2 Hengrui Medicine Business Overview
7.15.3 Hengrui Medicine Consumer Healthcare Drug Major Product Offerings
7.15.4 Hengrui Medicine Consumer Healthcare Drug Revenue in Global Market (2020-2025)
7.15.5 Hengrui Medicine Key News & Latest Developments
7.16 Fosun Pharma
7.16.1 Fosun Pharma Corporate Summary
7.16.2 Fosun Pharma Business Overview
7.16.3 Fosun Pharma Consumer Healthcare Drug Major Product Offerings
7.16.4 Fosun Pharma Consumer Healthcare Drug Revenue in Global Market (2020-2025)
7.16.5 Fosun Pharma Key News & Latest Developments
7.17 East China Medicine
7.17.1 East China Medicine Corporate Summary
7.17.2 East China Medicine Business Overview
7.17.3 East China Medicine Consumer Healthcare Drug Major Product Offerings
7.17.4 East China Medicine Consumer Healthcare Drug Revenue in Global Market (2020-2025)
7.17.5 East China Medicine Key News & Latest Developments
7.18 Livzon Group
7.18.1 Livzon Group Corporate Summary
7.18.2 Livzon Group Business Overview
7.18.3 Livzon Group Consumer Healthcare Drug Major Product Offerings
7.18.4 Livzon Group Consumer Healthcare Drug Revenue in Global Market (2020-2025)
7.18.5 Livzon Group Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Consumer Healthcare Drug Market Opportunities & Trends in Global Market
Table 2. Consumer Healthcare Drug Market Drivers in Global Market
Table 3. Consumer Healthcare Drug Market Restraints in Global Market
Table 4. Key Players of Consumer Healthcare Drug in Global Market
Table 5. Top Consumer Healthcare Drug Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Consumer Healthcare Drug Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Consumer Healthcare Drug Revenue Share by Companies, 2020-2025
Table 8. Global Companies Consumer Healthcare Drug Product Type
Table 9. List of Global Tier 1 Consumer Healthcare Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Consumer Healthcare Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type – Global Consumer Healthcare Drug Revenue, (US$, Mn), 2024 & 2031
Table 12. Segmentation by Type - Global Consumer Healthcare Drug Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Consumer Healthcare Drug Revenue (US$, Mn), 2026-2031
Table 14. Segmentation by Application– Global Consumer Healthcare Drug Revenue, (US$, Mn), 2024 & 2031
Table 15. Segmentation by Application - Global Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Consumer Healthcare Drug Revenue, (US$, Mn), 2026-2031
Table 17. By Region– Global Consumer Healthcare Drug Revenue, (US$, Mn), 2024 & 2031
Table 18. By Region - Global Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Consumer Healthcare Drug Revenue, (US$, Mn), 2026-2031
Table 20. By Country - North America Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Consumer Healthcare Drug Revenue, (US$, Mn), 2026-2031
Table 22. By Country - Europe Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Consumer Healthcare Drug Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Asia Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Consumer Healthcare Drug Revenue, (US$, Mn), 2026-2031
Table 26. By Country - South America Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Consumer Healthcare Drug Revenue, (US$, Mn), 2026-2031
Table 28. By Country - Middle East & Africa Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Consumer Healthcare Drug Revenue, (US$, Mn), 2026-2031
Table 30. Johnson & Johnson Corporate Summary
Table 31. Johnson & Johnson Consumer Healthcare Drug Product Offerings
Table 32. Johnson & Johnson Consumer Healthcare Drug Revenue (US$, Mn) & (2020-2025)
Table 33. Johnson & Johnson Key News & Latest Developments
Table 34. AbbVie Corporate Summary
Table 35. AbbVie Consumer Healthcare Drug Product Offerings
Table 36. AbbVie Consumer Healthcare Drug Revenue (US$, Mn) & (2020-2025)
Table 37. AbbVie Key News & Latest Developments
Table 38. Merck & Co. Corporate Summary
Table 39. Merck & Co. Consumer Healthcare Drug Product Offerings
Table 40. Merck & Co. Consumer Healthcare Drug Revenue (US$, Mn) & (2020-2025)
Table 41. Merck & Co. Key News & Latest Developments
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Consumer Healthcare Drug Product Offerings
Table 44. GlaxoSmithKline Consumer Healthcare Drug Revenue (US$, Mn) & (2020-2025)
Table 45. GlaxoSmithKline Key News & Latest Developments
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Consumer Healthcare Drug Product Offerings
Table 48. Pfizer Consumer Healthcare Drug Revenue (US$, Mn) & (2020-2025)
Table 49. Pfizer Key News & Latest Developments
Table 50. Sanofi Corporate Summary
Table 51. Sanofi Consumer Healthcare Drug Product Offerings
Table 52. Sanofi Consumer Healthcare Drug Revenue (US$, Mn) & (2020-2025)
Table 53. Sanofi Key News & Latest Developments
Table 54. Takeda Corporate Summary
Table 55. Takeda Consumer Healthcare Drug Product Offerings
Table 56. Takeda Consumer Healthcare Drug Revenue (US$, Mn) & (2020-2025)
Table 57. Takeda Key News & Latest Developments
Table 58. Bayer Corporate Summary
Table 59. Bayer Consumer Healthcare Drug Product Offerings
Table 60. Bayer Consumer Healthcare Drug Revenue (US$, Mn) & (2020-2025)
Table 61. Bayer Key News & Latest Developments
Table 62. Teva Corporate Summary
Table 63. Teva Consumer Healthcare Drug Product Offerings
Table 64. Teva Consumer Healthcare Drug Revenue (US$, Mn) & (2020-2025)
Table 65. Teva Key News & Latest Developments
Table 66. Sinopharm Group Corporate Summary
Table 67. Sinopharm Group Consumer Healthcare Drug Product Offerings
Table 68. Sinopharm Group Consumer Healthcare Drug Revenue (US$, Mn) & (2020-2025)
Table 69. Sinopharm Group Key News & Latest Developments
Table 70. CR Pharmaceutical Corporate Summary
Table 71. CR Pharmaceutical Consumer Healthcare Drug Product Offerings
Table 72. CR Pharmaceutical Consumer Healthcare Drug Revenue (US$, Mn) & (2020-2025)
Table 73. CR Pharmaceutical Key News & Latest Developments
Table 74. Shanghai Pharmaceuticals Corporate Summary
Table 75. Shanghai Pharmaceuticals Consumer Healthcare Drug Product Offerings
Table 76. Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue (US$, Mn) & (2020-2025)
Table 77. Shanghai Pharmaceuticals Key News & Latest Developments
Table 78. Hualan Bio Corporate Summary
Table 79. Hualan Bio Consumer Healthcare Drug Product Offerings
Table 80. Hualan Bio Consumer Healthcare Drug Revenue (US$, Mn) & (2020-2025)
Table 81. Hualan Bio Key News & Latest Developments
Table 82. North China Pharmaceutical Corporate Summary
Table 83. North China Pharmaceutical Consumer Healthcare Drug Product Offerings
Table 84. North China Pharmaceutical Consumer Healthcare Drug Revenue (US$, Mn) & (2020-2025)
Table 85. North China Pharmaceutical Key News & Latest Developments
Table 86. Hengrui Medicine Corporate Summary
Table 87. Hengrui Medicine Consumer Healthcare Drug Product Offerings
Table 88. Hengrui Medicine Consumer Healthcare Drug Revenue (US$, Mn) & (2020-2025)
Table 89. Hengrui Medicine Key News & Latest Developments
Table 90. Fosun Pharma Corporate Summary
Table 91. Fosun Pharma Consumer Healthcare Drug Product Offerings
Table 92. Fosun Pharma Consumer Healthcare Drug Revenue (US$, Mn) & (2020-2025)
Table 93. Fosun Pharma Key News & Latest Developments
Table 94. East China Medicine Corporate Summary
Table 95. East China Medicine Consumer Healthcare Drug Product Offerings
Table 96. East China Medicine Consumer Healthcare Drug Revenue (US$, Mn) & (2020-2025)
Table 97. East China Medicine Key News & Latest Developments
Table 98. Livzon Group Corporate Summary
Table 99. Livzon Group Consumer Healthcare Drug Product Offerings
Table 100. Livzon Group Consumer Healthcare Drug Revenue (US$, Mn) & (2020-2025)
Table 101. Livzon Group Key News & Latest Developments
List of Figures
Figure 1. Consumer Healthcare Drug Product Picture
Figure 2. Consumer Healthcare Drug Segment by Type in 2024
Figure 3. Consumer Healthcare Drug Segment by Application in 2024
Figure 4. Global Consumer Healthcare Drug Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Consumer Healthcare Drug Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Consumer Healthcare Drug Revenue: 2020-2031 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Consumer Healthcare Drug Revenue in 2024
Figure 9. Segmentation by Type – Global Consumer Healthcare Drug Revenue, (US$, Mn), 2024 & 2031
Figure 10. Segmentation by Type - Global Consumer Healthcare Drug Revenue Market Share, 2020-2031
Figure 11. Segmentation by Application – Global Consumer Healthcare Drug Revenue, (US$, Mn), 2024 & 2031
Figure 12. Segmentation by Application - Global Consumer Healthcare Drug Revenue Market Share, 2020-2031
Figure 13. By Region - Global Consumer Healthcare Drug Revenue Market Share, 2020-2031
Figure 14. By Country - North America Consumer Healthcare Drug Revenue Market Share, 2020-2031
Figure 15. United States Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 16. Canada Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 17. Mexico Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 18. By Country - Europe Consumer Healthcare Drug Revenue Market Share, 2020-2031
Figure 19. Germany Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 20. France Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 21. U.K. Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 22. Italy Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 23. Russia Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 24. Nordic Countries Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 25. Benelux Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 26. By Region - Asia Consumer Healthcare Drug Revenue Market Share, 2020-2031
Figure 27. China Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 28. Japan Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 29. South Korea Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 30. Southeast Asia Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 31. India Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 32. By Country - South America Consumer Healthcare Drug Revenue Market Share, 2020-2031
Figure 33. Brazil Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 34. Argentina Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 35. By Country - Middle East & Africa Consumer Healthcare Drug Revenue Market Share, 2020-2031
Figure 36. Turkey Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 37. Israel Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 38. Saudi Arabia Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 39. UAE Consumer Healthcare Drug Revenue, (US$, Mn), 2020-2031
Figure 40. Johnson & Johnson Consumer Healthcare Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. AbbVie Consumer Healthcare Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Merck & Co. Consumer Healthcare Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. GlaxoSmithKline Consumer Healthcare Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Pfizer Consumer Healthcare Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Sanofi Consumer Healthcare Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Takeda Consumer Healthcare Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Bayer Consumer Healthcare Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Teva Consumer Healthcare Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Sinopharm Group Consumer Healthcare Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. CR Pharmaceutical Consumer Healthcare Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Hualan Bio Consumer Healthcare Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. North China Pharmaceutical Consumer Healthcare Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 54. Hengrui Medicine Consumer Healthcare Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 55. Fosun Pharma Consumer Healthcare Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 56. East China Medicine Consumer Healthcare Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 57. Livzon Group Consumer Healthcare Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
